Bortezomib and Dexamethasone as Treatment and Maintenance for Multiple Myeloma Relapse

Mise à jour : Il y a 4 ans
Référence : NCT00335348

Femme et Homme

  • | Pays :
  • Australia
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

This study has two main aims. The first is to assess whether Dexamethasone can increase the number of patients with who respond to Velcade. The second aim of this study is to see whether treating patients with relapsed multiple myeloma with Velcade and Dexamethasone for a longer period of time extends the time that the myeloma is under control.


Critère d'inclusion

  • Multiple myeloma

Liens